Nasdaq News

(RTTNews) - NeuroSense Therapeutics Ltd. (NRSN), a late-stage clinical biotechnology company focused on treatments for neurodegenerative diseases, provided a business update and first-half 2026 financial results reflecting a narrower net loss.

Key PointsCurrent estimates are calling for a 3.5% to 3.6% Social Security COLA in 2027.

The S&P 500 Index ($SPX ) (SPY ) closed up by +0.51% on Friday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up by +0.93%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.42%. December E-mini S&P futures (ESZ26 ) rose +0.47%, and December E-mini...

Key PointsBased on its steady revenue and profit growth and durable moat, American Express is a high-quality business.

(RTTNews) - Burford Capital Limited (BUR, BUR.L) issued a statement regarding the verdict, in a case captioned Taction Technology, Inc. v. Apple Inc., which represents one of the largest patent verdicts in U.S. history. On September 25, a jury in a case in which Burford has a fin

Key PointsWilliams Companies has increased its dividend by 162% over the past decade.

XOM, ADP, CDNS and BOF feature in Zacks research, with AI, operational efficiency, recurring revenue and growth opportunities shaping their outlooks.

(RTTNews) - Agfa-Gevaert (AGFB.BR), an imaging technology company, on Monday announced that it has entered into a definitive agreement with Electronics for Imaging to combine Agfa's Digital Printing Solutions business with EFI.

KNSL, RLI, PLMR and SKWD are leveraging specialized underwriting, niche risks and disciplined strategies as specialty insurance demand expands.

Companies In The News Are: COST, PPLI, MGM, AKAM, SCHL.

(RTTNews) - Kodiak Sciences Inc. (KOD), a pre-commercial, retina-focused biotechnology company, is expected to report topline results from DAYBREAK, a Phase 3 study evaluating both Zenkuda (tarcocimab tedromer) and KSI-501 (tabirafusp alfa tedromer) in patients with wet age-relat

ADI, SMTC, TSM and ASMIY are positioned to benefit from AI-driven semiconductor demand, spanning chips, connectivity, advanced packaging and ALD.

People (PPLI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

AVY, ATR and KRT are navigating weak packaging demand with pricing, cost controls and growth in e-commerce and eco-friendly products.

(RTTNews) - Innovent Biologics, Inc. (1801.HK), a biopharmaceutical company focused on developing therapies across oncology and other major diseases, announced the expansion of the global Phase 3 MarsLight-11 study of IBI363/TAK-928 to include patients with non-squamous non-small

PL, SATL and GILT are tapping rising demand for satellite imagery, defense SATCOM and sovereign space infrastructure amid industry shifts.

EAT, SNPS and FE stand out for projected sales growth as investors assess stocks amid elevated yields, inflation and rate hike bets.

(RTTNews) - European stocks are seen opening on a cautious note on Monday due to continued uncertainty over the end to the U.S.-Iran war in the Middle East after U.S. President Donald Trump rejected Iran's latest proposal to reopen the Strait of Hormuz and signaled possible new m

BABA, BIDU, KC, TCEHY and HSAI highlight China's expanding AI ecosystem, while PONY and WRD add autonomous-driving exposure.

(RTTNews) - Hyloris Pharmaceuticals SA (HYL.BR) announced that its partner AFT Pharmaceuticals Ltd. (AFT.NZ) has entered into an exclusive agreement with Mikasa Seiyaku Co Ltd. for the commercialization of Maxigesic IV in Japan.